On Friday, 22 September 2017, a GCP/GPV training day was held with the subject: "Safety Information from a GCP Perspective".

The day started with a presentation on “Core concepts in pharmacovigilance auditing” by Marielle Keulen, Xendo. It was followed by presentations which covered different aspects of Safety information which included Reference Safety Information (RSI) from Clinical Trial and Post marketing perspectives, presented by Deepti Naik, PRA Health Sciences and Marielle Keulen.

Pharmacovigilance aspects which one comes across during day to day GCP or during monitoring was presented by Deepti Naik in her presentation “Safety information at investigator sites” hereby linking GCP and GPV. Final presentation for the day was on “Reference Safety Information from a QA perspective” presented by Laurentiu Chitimia, Astellas. The day concluded with a Q&A session with the speakers of the day.

Points of discussion were:

  • RSI- its importance and criticality
  • Changes to the regulations with regards to RSI
  • Commonly observed issues and audit findings related to RSI

Around 35 participants from different backgrounds including QA, Pharmacovigilance Operations attended the training day. The cross functionality of the topic linking GCP and GVP and the wide range of the audience backgrounds lead to lively discussions and a very interactive training day.

The presentations of this day are now available for download for our members. Sign in first and go to https://www.darqa.org/downloads/category/46-2017

The non-DARQA members who were present can send an email to the Dit e-mailadres wordt beveiligd tegen spambots. JavaScript dient ingeschakeld te zijn om het te bekijken. for sending the presentations.



Zimmer Biomet, one of the global leaders in the medical device market, has a vacancy for the position of

Quality Engineer

at the Clinical Graphics division in Delft, The Netherlands. Please send your complete resume via the 'Apply' button or call for further inquiries to Noblesse Recruitment: Monique Nobel +31 6 41 576 904.

DARQA Logo Regulatory Focus GroupDe DARQA Regulatory Focus Group heeft tot doel het becommentariëren en reviewen van nieuwe regelgeving, concept-guidelines en richtlijnen in revisie.

DARQA leden die betrokken willen worden bij de evaluatie en becommentariëring van nieuwe of gewijzigde wet- en regelgeving kunnen zich HIER aanmelden voor de Regulatory Focus Group op LinkedIN.

DARQA Nieuwsbrief

poppenDARQA stuurt ad hoc een Nieuwsbrief uit naar haar leden.
Ook niet-leden kunnen zich inschrijven op deze DARQA Nieuwsbrief

Aanmelden voor de DARQA Nieuwsbrief


Lid worden van DARQA?

lidwordenWordt ook lid van DARQA waar alle belangengroepen elkaar ontmoeten en informatie uitwisselen op het gebied van regelgeving, goede praktijken en ontwikkelingen.

Aanmelden voor lidmaatschap


evenementDe DARQA en haar commissies organiseren bijeenkomsten voor leden en niet-leden


Evenementen programma